pioglitazone has been researched along with bisphenol a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casini, A; Ceni, E; Crabb, DW; Galli, A; Mello, T; Ridolfi, F; Salzano, R; Surrenti, C; Svegliati-Baroni, G; Trozzi, L | 1 |
| Abdul Jaleel, UC; Balachandran, S; Benjamin, S; Doble, M; Pradeep, S; Sarath Josh, MK; Spener, F; Vijayalekshmi Amma, KS | 1 |
2 other study(ies) available for pioglitazone and bisphenol a
| Article | Year |
|---|---|
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
Topics: Animals; Benzhydryl Compounds; Bile Ducts; Carbon Tetrachloride; Cell Division; Cells, Cultured; Collagen; Dimethylnitrosamine; DNA; Epoxy Compounds; Fibronectins; Hypoglycemic Agents; Ligation; Liver; Liver Cirrhosis; Male; Phenols; Pioglitazone; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Phthalates efficiently bind to human peroxisome proliferator activated receptor and retinoid X receptor α, β, γ subtypes: an in silico approach.
Topics: Benzhydryl Compounds; Humans; Peroxisome Proliferator-Activated Receptors; Phenols; Phthalic Acids; Pioglitazone; Plasticizers; Protein Conformation; Retinoid X Receptor alpha; Retinoid X Receptor beta; Retinoid X Receptor gamma; Rosiglitazone; Thiazolidinediones | 2014 |